A new rapid diagnostic test for COVID-19, developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes, is being deployed at Cambridge hospitals, ahead of being launched in hospitals nationwide.

A rapid way of turning ideas into new technologies in the aviation and power industries has been developed at Cambridge’s Whittle Laboratory. Here, Professor Rob Miller, Director of the Whittle, describes how researchers plan to scale the process to cover around 80% of the UK’s future aerodynamic technology needs.

A rapid way of turning ideas into new technologies in the aviation and power industries has been developed at Cambridge’s Whittle Laboratory. Here, Professor Rob Miller, Director of the Whittle, describes how researchers plan to scale the process to cover around 80% of the UK’s future aerodynamic technology needs.

A combination of heart cells derived from human stem cells could be the answer to developing a desperately-needed treatment for heart failure, according to new research by scientists at the University of Cambridge, published in Nature Biotechnology.

A team of UK scientists have identified the mechanism behind hardening of the arteries, and shown in animal studies that a generic medication normally used to treat acne could be an effective treatment for the condition.

Collaboration between government and startups could help meet the climate challenge while growing small businesses. Findings could inform discussions on Green New Deal or any “forward-looking policy package” say researchers.